Propranolol in the management of recurrent migraine: a meta-analytic review.
about
Propranolol for migraine prophylaxisManual therapies for migraine: a systematic reviewAdvances in pharmacological treatment of migraineEFNS guideline on the drug treatment of migraine - report of an EFNS task forceProphylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover studyThe prevention of migraine: a critical review with special emphasis on beta-adrenoceptor blockersWITHDRAWN: Propranolol for migraine prophylaxis.Successful use of propranolol in migraine associated with electroconvulsive therapy.Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial.The clinician's approach to the management of headache.Behavioral treatment of migraine: current status and future directions.The importance of placebo in headache research.Migraine: preventive treatment.Beta-blocker migraine prophylaxis affects the excitability of the visual cortex as revealed by transcranial magnetic stimulation.Psychophysiologic Therapy for Chronic Headache in Primary Care.Preventive treatment of migraine: effect on weight.Behavioral headache treatment: history, review of the empirical literature, and methodological critique.Evidence-based medicine in migraine prevention.Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting.The pharmacotherapy of chronic pain: a review.Acceptance or rejection of prophylactic medicine in patients with migraine: a cross-sectional study.Migraine: a review and future directions for treatment.Propranolol's effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants: a meta-analysisOptimizing prophylactic treatment of migraine: Subtypes and patient matching.CADASIL management or what to do when there is little one can do.Tonabersat, a novel gap-junction modulator for the prevention of migraine.Behavioral treatment strategies for migraine and tension-type headache: a review of the evidence and future directions.Taking the negative view of current migraine treatments: the unmet needs.Behavioral treatment of headaches: extending the reach.The pathophysiological and pharmacological basis of current drug treatment of migraine headache.Biofeedback and behavioral treatments: filling some gaps.Safety of topiramate for treating migraines.Chronic migraine: risk factors, mechanisms and treatment.A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.Using a graphical risk tool to examine willingness to take migraine prophylactic medications.Direct costs of preventive headache treatments: comparison of behavioral and pharmacologic approaches.The effects of the multispecies probiotic mixture Ecologic®Barrier on migraine: results of an open-label pilot study.Cyclandelate in the prophylaxis of migraine: a placebo-controlled study.Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily.No effect of prophylactic treatment with metoprolol on cerebrovascular CO2 reactivity in migraineurs.
P2860
Q24247240-A298A9E9-E863-4E59-9875-85BD85CC130FQ24622838-F32583C3-585F-4BBD-92EF-E6C3136903BFQ28192002-3245BC75-650E-42F7-BD7C-E8EF4433884FQ28219436-769CF0DF-B53F-42C6-8C60-6EE6858A0C0CQ28345604-4C567A93-18BC-4646-A413-DF06DDA5CC05Q28354157-00A2296B-50FB-4C50-A801-70882AD124EEQ30235890-23F19085-3D6A-4F17-89A1-5D0AB35319D5Q31901040-3933DCFE-9871-4D00-A51F-A413A5E238E8Q34164195-EF9BA4FB-73CB-4AD5-8514-4099894A1464Q34187950-0CC4E136-7CD9-4749-86B8-FEB6F1B27F34Q34413888-474DFC01-34F2-45CA-AD7A-05C221865550Q34813721-70B007CB-7F2B-4093-9049-FECF31C16772Q34852689-0028E300-D662-46B0-9E87-FF09FA3F2DE7Q35658653-9CD8E33A-C8E8-40B0-BFCA-64C404BCF9CCQ35664402-07AD9905-8E68-4E22-AFF8-A6DDC8DC7F5BQ35987931-5BEFEF7C-37A8-4171-80E3-24F4F0E6B79EQ36142148-609645F2-8968-4F0C-AD0F-53FB8A092A08Q36153368-4B7AACF6-DBA1-403C-AEFA-CB2EB93142F5Q36260883-D1A7E142-495E-42BC-AE11-62EEB38BA598Q36411163-7C07C6FB-3C2C-4BCE-9A41-8681F638F6F9Q36445565-5EB173D8-27DF-42E0-8DA8-AE641EBD7BD9Q36546603-06556A12-A79D-42D4-96CB-79667E81DD61Q36955320-A7E519B7-8E11-4728-B5A5-F488F469C7FCQ37052803-224C5BA8-D26F-48E2-A1F9-DEEB2BC05B1DQ37390715-772759BE-E7C1-41C8-8F2F-0CB01DF61926Q37590396-AAEDD804-9741-4236-B092-DB8DADA4CF21Q37610272-8DE408F5-0B4C-43B7-B1FB-E37ACBE964E7Q38004092-631E8BF6-FF08-4B64-A7F5-51380734C67EQ38014296-C75AAB77-B405-4032-8BA3-36D07B73BBB5Q38105147-10D31DFC-ED80-40E6-95E8-185A91F09EECQ38215471-8AB9E7CC-F774-450E-AE90-073AEE8C1F1DQ38237259-9AEE5663-FD19-4058-934A-3DE5E3A8FFBBQ38889450-6AD15528-4CA1-4008-9386-7FE7816E862AQ41571135-7F7CFBE4-FA3A-4DF0-A0C1-02ECD54591CCQ41655641-30545E8A-A242-48D4-BD18-C94D65B81C84Q42174493-84B2BC87-856E-4910-9A59-35E245825BD6Q43456424-7E7519E8-1B13-46F7-892B-8B71719DC579Q43572328-09C6A170-5749-40B3-B2E0-64DE45FEF765Q44016434-2FC7D6BD-5B06-4CC6-82AD-EEF2DE288A73Q50867299-C64ABF22-F097-4205-BD28-88480BFFC42C
P2860
Propranolol in the management of recurrent migraine: a meta-analytic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Propranolol in the management of recurrent migraine: a meta-analytic review.
@en
Propranolol in the management of recurrent migraine: a meta-analytic review.
@nl
type
label
Propranolol in the management of recurrent migraine: a meta-analytic review.
@en
Propranolol in the management of recurrent migraine: a meta-analytic review.
@nl
prefLabel
Propranolol in the management of recurrent migraine: a meta-analytic review.
@en
Propranolol in the management of recurrent migraine: a meta-analytic review.
@nl
P1433
P1476
Propranolol in the management of recurrent migraine: a meta-analytic review
@en
P2093
G E Cordingley
K A Holroyd
P304
P356
10.1111/J.1526-4610.1991.HED3105333.X
P577
1991-05-01T00:00:00Z